We got more work to do. I get why we approve those, but is your approval pathway linked to the price of the drug or is it linked to safety and efficacy of The FDA's approval pathway is linked to safety and efficacy of the drug. So when the commissioner says that the price of a drug is going to influence the approval pathway, does that conform to the mandate? I'm not aware of what he said. (02:25–02:33)
CLAIM
Asserts that the FDA's drug approval process is based on safety and efficacy, not pricing.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
